Figure 4

Proportion of patients on standard or adjusted dose on the base of the baseline characteristics potentially influencing the dose choice among 927,523 NOAC treatments in AIFA Registry.
Proportion of patients on standard or adjusted dose on the base of the baseline characteristics potentially influencing the dose choice among 927,523 NOAC treatments in AIFA Registry.